|

Amiloride Clinical Trials

2 actively recruiting trials across 2 locations

▲ +1 trial since June 2026

Also known as: Amiloride Topical Eye Drops

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • Yale University1
  • Laura Huppert, MD, BA1

Indications

  • Heart Disease1
  • HER2 Low Breast Carcinoma1
  • Hormone Receptor Positive Breast Carcinoma1
  • Triple Negative Breast Cancer1
  • Hormone Receptor Positive Breast Cancer1

San Francisco, California1 trial

ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer

University of California, San Francisco

Phase 2

New Haven, Connecticut1 trial

Mechanisms of Diuretic Resistance in Heart Failure, Aim 2

Yale University

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.